Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2750
Single User License Price INR 192500
Corporate User License Price USD 4500
Corporate User License Price INR 315000
Site License Price USD 3500
Site License Price INR 245000
Request a Quote

Report Title

Global Transdermal Drug Delivery Market Trends and Drivers, Restraints, and Opportunities 2017-2023

Quote Request for License Type
License Type Price  
Single User License USD 2750
Site License USD 3500
Enterprise Wide License USD 4500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Global Transdermal Drug Delivery Market Trends and Drivers, Restraints, and Opportunities 2017-2023


Quote Request for License Type
License Type Price  
Single User License USD 2750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Global Transdermal Drug Delivery Market Trends and Drivers, Restraints, and Opportunities 2017-2023

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Global Transdermal Drug Delivery Market Trends and Drivers, Restraints, and Opportunities 2017-2023



Executive Summary

Transdermal Drug Delivery Market-Global Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017-2023

Overview: Transdermal drug delivery system (TDDS) is an independent, distinct dosage form of drug applied to intact skin to deliver the drug at a meticulous rate to the blood. The transdermal route of governing the drugs is known to be one of the budding route for indigenous and systemic drug delivery process.

The first transdermal drug delivery system, Transderm-SCOP received US FDA approval in the year 1979 for the stoppage of nausea and vomiting. Since then the technology has greatly developed. The first-generation transdermal drug delivery majorly involved delivery of small, lipophilic, and uncharged molecules by passive diffusion technology. Maximum products that are currently available in the market belong to this generation. However, development of technology has led to the use of chemical enhancers and other energy-based techniques such as ultrasound to enhance the permeation of the drug through the skin. They belong to the second generation of transdermal products. The delivery of lidocaine is done by an iontophoretic delivery system, which was developed and marketed during this generation. A third generation of delivery systems are the ones that are currently under development including microneedles and electroporation to deliver macromolecules.

Market Analysis: The Global Transdermal Drug Delivery Market is estimated to witness a CAGR of 9.5% during the forecast period 2017-2023. The Transdermal Drug Delivery market is analyzed based on four segments-Product Type, Technology, Drug Type, and Regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). In the North American region, the US is set to be the leading country. The Europe is set to be the second leading region and holds more than 26.3% of the market share in 2016. In Asia Pacific, India, Japan, and China is one of the most attractive countries for the players and holds huge business opportunities. RoW is set to be an emerging market in the next 5-6 years.

Technology Analysis: Based on the technology types, the market is segmented into Passive and Active transdermal technology. At present the market is dominated by passive technology. However, the advent of novel technology for enhancing the permeation of drugs through skin the skin is driving the market growth. Hence the highest growth rate is expected to be in witnessed in the active transdermal drug delivery technology.

Product Types Analysis: The product types covered in the report are Patches and Gels. Transdermal Patches are likely to continue to dominate the market by 2023. Stringent regulatory approval and high cost of the transdermal drug delivery systems represents as the major challenge the growth of transdermal drug delivery market. The market is expected to be on a positive year on year growth rate, as the increase in chronic diseases prevalence and expanded application areas of the technology is expected during the forecast period.

Key Players: 3M, Boehringer Ingelheim, Johnson and Johnson, Mylan N.V., Novartis, and GlaxoSmithKline, are the key players in the market. Echo Therapeutics Inc., Noven Pharmaceuticals, Transdermal Corp, Actavis, Bayer, and Corium International, are the other key players in the market.

Competitive Analysis: The transdermal drug delivery market is highly lucrative. Many players are developing advanced technology products and if involved in expanding the application areas of these drug delivery systems. In 2017, Nemaura Pharma, a UK-based company has developed Memspatch, to increase the penetration rate of gel by three-times faster than the ones that are already available in the market. Apart from this the major players in the market are collaborating with other major players in the market. For instance, In January 2017, 3M Drug Delivery Systems entered into collaboration with Panacea Pharmaceuticals, Inc. to deliver a new therapeutic cancer vaccine directly to the dermis through the 3M Hollow Microstructure Transdermal System (hMTS).

Benefits: The report provides complete details about the usage and adoption rate of transdermal drug delivery in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player's initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Key Stakeholders:

Table of Contents

1 Industry Outlook 9

1.1 Industry Overview 9

1.2 Industry Trends 9

1.3 Total Addressable Market 10

2 Report Outline 11

2.1 Report Scope 11

2.2 Report Summary 11

2.3 Research Methodology 12

2.4 Report Assumptions 13

3 Market Snapshot 13

3.1 Market Definition-Infoholic Research 14

3.2 Segmented Addressable Market 14

3.2.1 Components of Transdermal Patch 15

3.2.2 Advantages of Transdermal Drug Delivery 15

3.2.3 Disadvantages of Transdermal Drug Delivery 15

3.2.4 Diseases Treated by Transdermal Drug Delivery Systems 15

3.2.5 Trends in Transdermal Drug Delivery Market 16

3.3 Related Markets 17

3.3.1 Active Pharmaceutical Ingredients 17

3.3.2 Pulmonary Drug Delivery Systems 18

3.3.3 Injectable Drug Delivery Systems 18

4 Market Outlook 19

4.1 Overview 19

4.2 Market Segmentation 20

4.3 Porter 5(Five) Forces 20

4.4 PEST Analysis 21

5 Market Characteristics 22

5.1 Market Dynamics 22

5.1.1 Drivers 23

5.1.1.1 Increasing aging population 23

5.1.1.2 Growing patient base of chronic diseases 23

5.1.1.3 Increasing demand for transdermal drug delivery 24

5.1.2 Opportunities 24

5.1.2.1 Increased healthcare spending 24

5.1.2.2 Increasing clinical trials and product launches 24

5.1.3 Restraints 25

5.1.3.1 Side effects of transdermal drug delivery 25

5.1.3.2 Delivery limitation through skin 25

5.1.3.3 Availability of alternative drug delivery systems 26

5.2 DRO-Impact Analysis 26

5.3 Key Stakeholders 26

6 Types: Market Size and Analysis 27

6.1 Overview 27

6.2 Patches 28

6.3 Gels 29

7 Technology: Market Size and Analysis 29

7.1 Overview 30

7.2 Passive 30

7.3 Active 30

7.3.1 Thermal Technology 31

7.3.2 Ultrasound Devices 31

7.3.3 Electrical Techniques 31

7.3.4 Mechanical Methods 32

7.3.5 Velocity-based Devices 33

8 Drug Types: Market Size and Analysis 33

8.1 Overview 33

8.2 Fentanyl 33

8.3 Nicotine Transdermal Patch 34

8.4 Nitroglycerin Transdermal Patch 34

8.5 Clonidine Transdermal Patch 34

8.6 Estradiol 35

8.7 Testosterone 35

8.8 Others 35

9 Regions: Market Size and Analysis 35

9.1 Overview 35

9.2 North America 36

9.2.1 Overview 36

9.3 Europe 38

9.3.1 Overview 38

9.4 Asia Pacific 39

9.4.1 Overview 39

9.5 Rest of the World 40

9.5.1 Overview 40

10 Competitive Landscape 41

11 Vendor Profiles 44

11.1 Novartis AG 44

11.1.1 Overview 44

11.1.2 Business Units 47

11.1.3 Geographic Revenue 48

11.1.4 Business Focus 49

11.1.5 SWOT Analysis 49

11.1.6 Business Strategies 50

11.2 3M 51

11.2.1 Overview 51

11.2.2 Business Units 52

11.2.3 Geographic Revenue 53

11.2.4 Business Focus 54

11.2.5 SWOT Analysis 55

11.2.6 Business Strategies 55

11.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) 55

11.3.1 Overview 55

11.3.2 Business Units 59

11.3.3 Geographic Revenue 60

11.3.4 Business Focus 61

11.3.5 SWOT Analysis 62

11.3.6 Business Strategies 63

11.4 GlaxoSmithKline plc 63

11.4.1 Overview 63

11.4.2 Business Units 65

11.4.3 Geographic Revenue 66

11.4.4 Business Focus 67

11.4.5 SWOT Analysis 67

11.4.6 Business Strategies 68

11.5 Boehringer Ingelheim GmbH 68

11.5.1 Overview 68

11.5.2 Business Units 70

11.5.3 Geographic Revenue 71

11.5.4 Business Focus 72

11.5.5 SWOT Analysis 72

11.5.6 Business Strategies 73

11.6 Mylan N.V. 73

11.6.1 Overview 73

11.6.2 Business Units 75

11.6.3 Geographic Revenue 77

11.6.4 Business Focus 77

11.6.5 SWOT Analysis 77

11.6.6 Business Strategies 78

12 Companies to Watch For 78

12.1 Echo Therapeutics, Inc. 78

12.1.1 Overview 78

12.1.2 Highlights 79

12.2 Noven Pharmaceuticals, Inc. 79

12.2.1 Overview 79

12.2.2 Highlights 80

12.3 Transdermal Corp. 80

12.3.1 Overview 80

12.4 Bayer AG 81

12.4.1 Overview 81

12.5 Actavis, Inc. 82

12.5.1 Overview 82

12.6 Corium International, Inc. 82

12.6.1 Overview 82

Annexure 84

Abbreviations 84

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL TRANSDERMAL DRUG DELIVERY MARKET 13

CHART 2 GLOBAL TRANSDERMAL DRUG DELIVERY MARKET REVENUE, 2016-2023 (USD MILLION) 18

CHART 3 SEGMENTATION OF GLOBAL TRANSDERMAL DRUG DELIVERY MARKET 21

CHART 4 PORTER 5 FORCES OF TRANSDERMAL DRUG DELIVERY MARKET 21

CHART 5 PEST ANALYSIS OF TRANSDERMAL DRUG DELIVERY MARKET 22

CHART 6 MARKET DYNAMICS-DRO ANALYSIS 23

CHART 7 DRO-IMPACT ANALYSIS OF GLOBAL TRANSDERMAL DRUG DELIVERY MARKET 27

CHART 8 KEY STAKEHOLDERS 27

CHART 9 TRANSDERMAL DRUG DELIVERY MARKET SHARE BY TYPES SEGMENTATION, 2016 VS 2023 (%) 28

CHART 10 TRANSDERMAL DRUG DELIVERY PATCHES MARKET REVENUE BY TYPES SEGMENTATION, 2016-2023 (USD MILLION) 29

CHART 11 TRANSDERMAL DRUG DELIVERY GELS MARKET REVENUE BY TYPES SEGMENTATION, 2016-2023 (USD MILLION) 30

CHART 12 TRANSDERMAL DRUG DELIVERY MARKET SHARE BY TECHNOLOGY SEGMENTATION, 2016 (%) 31

CHART 13 TRANSDERMAL DRUG DELIVERY MARKET SHARE BY DRUG TYPE, 2016 (%) 34

CHART 14 TRANSDERMAL DRUG DELIVERY MARKET SHARE BY REGIONAL SEGMENTATION, 2016 VS 2023 (%) 36

CHART 15 TRANSDERMAL DRUG DELIVERY MARKET REVENUE IN NORTH AMERICA, 2016-2023 (USD MILLION) 38

CHART 16 TRANSDERMAL DRUG DELIVERY MARKET REVENUE IN EUROPE, 2016-2023 (USD MILLION) 39

CHART 17 TRANSDERMAL DRUG DELIVERY MARKET REVENUE IN ASIA PACIFIC, 2016-2023 (USD MILLION) 41

CHART 18 TRANSDERMAL DRUG DELIVERY MARKET REVENUE IN REST OF THE WORLD, 2016-2023 (USD MILLION) 42

CHART 19 NOVARTIS AG: OVERVIEW SNAPSHOT 47

CHART 20 NOVARTIS AG: BUSINESS UNITS 48

CHART 21 NOVARTIS AG: GEOGRAPHIC REVENUE 49

CHART 22 NOVARTIS AG: SWOT ANALYSIS 50

CHART 23 3M: OVERVIEW SNAPSHOT 52

CHART 24 3M: BUSINESS UNITS 53

CHART 25 3M: GEOGRAPHIC REVENUE 54

CHART 26 3M: SWOT ANALYSIS 56

CHART 27 JOHNSON & JOHNSON: OVERVIEW SNAPSHOT 59

CHART 28 JOHNSON & JOHNSON: BUSINESS UNITS 60

CHART 29 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE 61

CHART 30 JOHNSON & JOHNSON: SWOT ANALYSIS 63

CHART 31 GLAXOSMITHKLINE PLC: OVERVIEW SNAPSHOT 66

CHART 32 GLAXOSMITHKLINE PLC: BUSINESS UNITS 66

CHART 33 GLAXOSMITHKLINE PLC: GEOGRAPHIC REVENUE 67

CHART 34 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 68

CHART 35 BOEHRINGER INGELHEIM GMBH: OVERVIEW SNAPSHOT 70

CHART 36 BOEHRINGER INGELHEIM GMBH: BUSINESS UNITS 71

CHART 37 BOEHRINGER INGELHEIM GMBH: GEOGRAPHIC REVENUE 72

CHART 38 BOEHRINGER INGELHEIM GMBH: SWOT ANALYSIS 73

CHART 39 MYLAN N.V. OVERVIEW SNAPSHOT 75

CHART 40 MYLAN N.V.: BUSINESS SEGMENTS 76

CHART 41 MYLAN N.V.: GEOGRAPHIC REVENUE 78

CHART 42 MYLAN N.V.: SWOT ANALYSIS 78

Tables

TABLE 1 TRANSDERMAL DRUG DELIVERY MARKET REVENUE BY REGIONS, 2016-2023 (USD MILLION) 36

TABLE 2 PROMINENT VENDORS IN THE MARKET 42

TABLE 3 NOVARTIS AG: OFFERINGS 45

TABLE 4 NOVARTIS AG: RECENT DEVELOPMENTS 45

TABLE 5 3M: OFFERINGS 51

TABLE 6 3M: RECENT DEVELOPMENTS 51

TABLE 7 JOHNSON & JOHNSON: PRODUCT OFFERINGS 56

TABLE 8 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 56

TABLE 9 GLAXOSMITHKLINE PLC: OFFERINGS 63

TABLE 10 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 64

TABLE 11 BOEHRINGER INGELHEIM GMBH: OFFERINGS 69

TABLE 12 BOEHRINGER INGELHEIM GMBH: RECENT DEVELOPMENTS 69

TABLE 13 MYLAN N.V.: OFFERINGS 74

TABLE 14 MYLAN N.V.: RECENT DEVELOPMENTS 74

TABLE 15 ECHO THERAPEUTICS, INC.: OVERVIEW 79

TABLE 16 NOVEN PHARMACEUTICALS, INC.: OVERVIEW 79

TABLE 17 TRANSDERMAL CORP.: OVERVIEW 80

TABLE 18 BAYER AG: OVERVIEW 81

TABLE 19 BAYER AG: RECENT DEVELOPMENTS 81

TABLE 20 ACTAVIS, INC.: OVERVIEW 82

TABLE 21 CORIUM INTERNATIONAL, INC.: OVERVIEW 82

TABLE 22 CORIUM INTERNATIONAL, INC.: RECENT DEVELOPMENTS 83

3M, Boehringer Ingelheim, Johnson and Johnson, Mylan N.V., Novartis, and GlaxoSmithKline, are the key players in the market. Echo Therapeutics Inc., Noven Pharmaceuticals, Transdermal Corp, Actavis, Bayer, and Corium International, are the other key players in the market


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person